• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  06/25/2010
Trade Name:  Serevent
Generic Name or Proper Name (*):  salmeterol
Indications Studied:  Asthma
Label Changes Summary:  * Available data from controlled clinical trials suggest that Long Acting Beta Agonists (LABAs) increase the risk of asthma-related hospitalization in pediatric and adolescent patients. For pediatric and adolescent patients with asthma who require addition of a LABA to an inhaled corticosteroid, a fixed-dose combination product containing both an inhaled corticosteroid and LABA should ordinarily be used to ensure adherence with both drugs. In cases where use of a separate long-term asthma control medication (e.g. inhaled corticosteroid) and LABA is clinically indicated, appropriate steps must be taken to ensure adherence with both treatment components.
Product Labeling:  Labeling  Opens a new window
Sponsor:  GlaxoSmithKline
Pediatric Exclusivity Granted Date:  03/09/2006
Therapeutic Category:  Antiasthmatic